Patents by Inventor Dongqing ZHU

Dongqing ZHU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12312378
    Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a manual of joint and bone disorders such as arthritis and osteoporosis.
    Type: Grant
    Filed: June 20, 2023
    Date of Patent: May 27, 2025
    Assignee: RISEN (SUZHOU) PHARMA TECH CO., LTD.
    Inventors: Xianqi Kong, Jiasheng Lu, Jiamin Gu, Xiang Ji, Daiqiang Hu, Xiuchun Zhang, Xinyong Lv, Jinchao Ai, Dongdong Wu, Lin Wang, Dongqing Zhu, Xiaolin He
  • Publication number: 20240190859
    Abstract: There are provided isotope-enriched compounds containing stable heavy isotope-enriched amide functional groups for modulating the pharmacokinetic profile, metabolic profile, and/or delivery efficiency of a drug or prodrug, as well as its therapeutic or prophylactic efficacy and/or adverse effects. Use of the isotope-enriched amide-containing drugs and prodrugs for the treatment or prevention of disease states and conditions is also provided.
    Type: Application
    Filed: December 12, 2023
    Publication date: June 13, 2024
    Inventors: Jiasheng LU, Jiamin GU, Xiang JI, Dongqing ZHU, Xiaolin HE, Xianqi KONG
  • Patent number: 11970490
    Abstract: There are provided isotope-enriched compounds containing stable heavy isotope-enriched amide functional groups for modulating the pharmacokinetic profile, metabolic profile, and/or delivery efficiency of a drug or prodrug, as well as its therapeutic or prophylactic efficacy and/or adverse effects. Use of the isotope-enriched amide-containing drugs and prodrugs for the treatment or prevention of disease states and conditions is also provided.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: April 30, 2024
    Assignees: RISEN (SUZHOU) PHARMA TECH CO., LTD., SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
    Inventors: Jiasheng Lu, Jiamin Gu, Xiang Ji, Dongqing Zhu, Xiaolin He, Xianqi Kong
  • Publication number: 20240051982
    Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a manual of joint and bone disorders such as arthritis and osteoporosis.
    Type: Application
    Filed: June 20, 2023
    Publication date: February 15, 2024
    Inventors: Xianqi KONG, Jiasheng LU, Jiamin GU, Xiang JI, Daiqiang HU, Xiuchun ZHANG, Xinyong LV, Jinchao AI, Dongdong WU, Lin WANG, Dongqing ZHU, Xiaolin HE
  • Publication number: 20240000761
    Abstract: There are provided isotope-enriched compounds containing stable heavy isotope-enriched amide functional groups for modulating the pharmacokinetic profile, metabolic profile, and/or delivery efficiency of a drug or prodrug, as well as its therapeutic or prophylactic efficacy and/or adverse effects. Use of the isotope-enriched amide-containing drugs and prodrugs for the treatment or prevention of disease states and conditions is also provided.
    Type: Application
    Filed: March 25, 2021
    Publication date: January 4, 2024
    Inventors: Jiasheng LU, Jiamin GU, Xiang JI, Dongqing ZHU, Xiaolin HE, Xianqi KONG
  • Patent number: 11718636
    Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis and osteoporosis.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: August 8, 2023
    Assignee: RISEN (SUZHOU) PHARMA TECH CO., LTD.
    Inventors: Xianqi Kong, Jiasheng Lu, Jiamin Gu, Xiang Ji, Daiqiang Hu, Xiuchun Zhang, Xinyong Lv, Jinchao Ai, Dongdong Wu, Lin Wang, Dongqing Zhu, Xiaolin He
  • Publication number: 20230227488
    Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis and osteoporosis.
    Type: Application
    Filed: January 18, 2023
    Publication date: July 20, 2023
    Inventors: Jiasheng LU, Jiamin GU, Xiang JI, Daiqiang HU, Xiuchun ZHANG, Xinyong LV, Jinchao AI, Dongdong WU, Xianqi KONG, LIN WANG, Dongqing ZHU, Xiaolin HE
  • Patent number: 11591358
    Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis and osteoporosis.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: February 28, 2023
    Assignee: RISEN (SUZHOU) PHARMA TECH CO., LTD.
    Inventors: Jiasheng Lu, Jiamin Gu, Xiang Ji, Daiqiang Hu, Xiuchun Zhang, Xinyong Lv, Jinchao Al, Dongdong Wu, Xianqi Kong, Lin Wang, Dongqing Zhu, Xiaolin He
  • Publication number: 20220002285
    Abstract: There are provided isotope-enriched compounds containing stable heavy isotope-enriched amide functional groups for modulating the pharmacokinetic profile, metabolic profile, and/or delivery efficiency of a drug or prodrug, as well as its therapeutic or prophylactic efficacy and/or adverse effects. Use of the isotope-enriched amide-containing drugs and prodrugs for the treatment or prevention of disease states and conditions is also provided.
    Type: Application
    Filed: March 25, 2021
    Publication date: January 6, 2022
    Inventors: Jiasheng LU, Jiamin GU, Xiang JI, Dongqing ZHU, Xiaolin HE, Xianqi KONG
  • Publication number: 20210079033
    Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis and osteoporosis.
    Type: Application
    Filed: December 17, 2018
    Publication date: March 18, 2021
    Inventors: Xianqi KONG, Jiasheng LU, Jiamin GU, Xiang JI, Daiqiang HU, Xiuchun ZHANG, Xinyong LV, Jinchao AI, Dongdong WU, Lin WANG, Dongqing ZHU, Xiaolin HE
  • Publication number: 20190185502
    Abstract: There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis and osteoporosis.
    Type: Application
    Filed: December 17, 2018
    Publication date: June 20, 2019
    Inventors: Jiasheng LU, Jiamin GU, Xiang JI, Daiqiang HU, Xiuchun ZHANG, Xinyong LV, Jinchao AI, Dongdong WU, Xianqi KONG, Lin WANG, Dongqing ZHU, Xiaolin HE